Evidence map

ReviewWorld journal of gastroenterology2024

GLP-1, GIP/GLP-1, and GCGR/GLP-1 receptor agonists: Novel therapeutic agents for metabolic dysfunction-associated steatohepatitis.

Anmol Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

27 papers cite it

2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 39735270